Xcout IntelSYNCONA LIMITED competitors & alternatives
The 12 closest competitors and alternatives to SYNCONA LIMITED among asset management companies — ranked by similarity to what SYNCONA LIMITED actually does, not by market-cap band.
Subscribe to see SYNCONA LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About SYNCONA LIMITED
Syncona Ltd. is a closed-end investment fund, which engages in delivering returns from investments in long and alternative investment funds across multiple asset classes and targets. Its portfolio includes commercial companies, late-stage clinical companies, clinical companies, and pre-clinical companies. The company was founded on August 14, 2012 and is headquartered in St. Peter Port, the United Kingdom.
SYNCONA LIMITED at a glance
SYNCONA LIMITED is an asset management company headquartered in London, United Kingdom. It is publicly listed (SYNC) with a market capitalisation of $944.6M. Xcout tracks 8 named people at SYNCONA LIMITED, including Melanie Gee (Chair).
SYNCONA LIMITED leadership
- Melanie GeeChair
- Andrew KauDirector
- Gian Piero ReverberiNon-Executive Director
- JOHN ROCHENon-Executive Director
- Julie CherringtonNon-Executive Director
- Kemal MalikSenior Independent Director
2 more named people on record for SYNCONA LIMITED, with roles, board committees and tenure — see the full roster →
Top 12 SYNCONA LIMITED competitors
Ranked by semantic similarity — how close each company is to SYNCONA LIMITED by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar asset management company
Onward Opportunities Ltd. operates as a closed-ended investment vehicle, primarily targeting smaller UK enterprises that are publicly listed on the London Stock Exchange. The company commenced operations on January 31, 2023, and is officially based in Saint Peter Port, United Kingdom.
Similar asset management company
River UK Micro Cap Ltd. operates as a closed-end investment vehicle, primarily constructing its portfolio from small-capitalisation companies based in the United Kingdom. This entity was founded on October 2, 2014, and maintains its principal office in Saint Peter Port, Guernsey.
Similar asset management company
Draper Esprit VCT plc operates as a venture capital trust and fund manager, focusing primarily on direct investments. The firm's investment strategy covers all venture stages, including early, mid, and late-stage opportunities, with a particular emphasis on growth capital. It allocates capital to businesses predominantly in the healthcare, software, and services sectors, with its geographical investment scope limited to the United Kingdom.
Similar asset management company
Schroders Capital Global Innovation Trust Plc functions as a closed-ended investment fund. Its primary goal is to generate substantial capital appreciation over an extended period. This is accomplished by primarily allocating its capital to a diverse portfolio of British enterprises, which includes both those traded on public exchanges and those that are privately owned. The entity was founded on January 26, 2015, and its main operational base is located in London, United Kingdom.
Similar asset management company
Seneca Growth Capital VCT plc operates as a venture capital trust, primarily focusing on providing growth-stage financing. The trust allocates capital to emerging biotechnology firms, with a strong inclination towards both unlisted and publicly traded companies within the MedTech industry. Its investment scope extends geographically across the United Kingdom, the French regions of Île-de-France and Burgundy, and other mature European markets. Financially, the fund typically targets businesses boasting annual revenues exceeding £10 million (around $11.90 million), a gross profit margin greater than 50%, and an operating profit margin above 10%.
Similar asset management company
Operating as a closed-end investment vehicle, Tetragon Financial Group Ltd. allocates capital across an extensive range of asset classes. Its comprehensive portfolio spans bank loans, real estate, public equities, various credit products, convertible bonds, private equity stakes, and infrastructure, alongside its TFG Asset Management segment. The fund's objective is to generate stable and consistent returns for its investors, successfully navigating different market conditions including credit, equity, interest rate, and real estate cycles. Reade Eugene Griffith and Patrick Giles Gauntlet Dear established the company on June 23, 2005, with its principal office situated in London, United Kingdom.
Similar asset management company
Tetragon Financial Group Ltd. is a closed-end investment fund, which invests in assets. Its investments include bank loans, real estate, equities, credit, convertible bonds, private equity, infrastructure, and TFG Asset Management. It aims to provide stable returns to investors in credit, equity, interest rate, and real estate cycles. It operates through the following geographical segments: Europe, North America, Asia Pacific, and Latin America. The company was founded by Reade Eugene Griffith and Patrick Giles Gauntlet Dear on June 23, 2005 and is headquartered in London, United Kingdom.
Biotech
Monograph Capital is a life-sciences investment firm that provides venture capital to companies developing innovative therapeutics and related healthcare technologies. It works with entrepreneurs and management teams building businesses in the biotechnology and healthcare sectors.
Similar asset management company
The Biotech Growth Trust PLC, a closed-ended equity investment vehicle, was originally established by Frostrow Capital LLP and is jointly managed by OrbiMed Capital LLC. Formed on May 20, 1997, and legally based in the United Kingdom, this trust allocates its capital to global public equity markets. Its primary objective is to invest in shares of companies operating within the biotechnology sector, spanning the full range of market capitalizations. The construction of its investment portfolio relies on rigorous fundamental analysis, and its performance is benchmarked against the NASDAQ Biotechnology Index. It was previously identified as Finsbury Emerging Biotechnology Trust PLC.
Similar asset management company
Artemis UK Future Leaders PLC is a UK-incorporated, closed-end investment company. Its primary objective is to achieve long-term capital appreciation by investing in a carefully selected portfolio of publicly traded securities. While primarily focused on the UK equity markets, the fund typically allocates its investments to smaller companies.
Similar asset management company
Intuitive Investments Group Plc seeks to allocate capital to both nascent and more established companies within the life sciences sector. Its primary geographic focus for these investments spans the United Kingdom, mainland Europe, and the United States. The firm was founded in 2020 and is headquartered in London, UK.
Similar asset management company
Casdin Capital is an investment firm focused on the life sciences and healthcare sectors, including biotechnology, medical technology, and related companies. It serves institutional and other sophisticated investors through investment strategies targeting growth and innovation in healthcare.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of SYNCONA LIMITED and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for SYNCONA LIMITEDand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →